Exagen Inc (XGN)

Exagen (XGN) Stock Price & Analysis


XGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.04 - $8.96
Previous Close$3.15
Average Volume (3M)19.33K
Market Cap
Enterprise Value$35.45M
Total Cash (Recent Filing)$52.18M
Total Debt (Recent Filing)$34.63M
Price to Earnings (P/E)-1.2
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.61
Shares Outstanding16,825,696
10 Day Avg. Volume5,327
30 Day Avg. Volume19,327
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)2.07
Price to Sales (P/S)4.72
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.76
Enterprise Value/Gross Profit1.66
Enterprise Value/Ebitda-0.84
Price Target Upside73.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Exagen Inc’s price range in the past 12 months?
Exagen Inc lowest stock price was $2.04 and its highest was $8.96 in the past 12 months.
    What is Exagen Inc’s market cap?
    Currently, no data Available
    When is Exagen Inc’s upcoming earnings report date?
    Exagen Inc’s upcoming earnings report date is Aug 02, 2023 which is in 55 days.
      How were Exagen Inc’s earnings last quarter?
      Exagen Inc released its earnings results on May 15, 2023. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.562 by $0.122.
        Is Exagen Inc overvalued?
        According to Wall Street analysts Exagen Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Exagen Inc pay dividends?
          Exagen Inc does not currently pay dividends.
          What is Exagen Inc’s EPS estimate?
          Exagen Inc’s EPS estimate is -$0.5.
            How many shares outstanding does Exagen Inc have?
            Exagen Inc has 16,825,697 shares outstanding.
              What happened to Exagen Inc’s price movement after its last earnings report?
              Exagen Inc reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.562. Following the earnings report the stock price went up 19.588%.
                Which hedge fund is a major shareholder of Exagen Inc?
                Among the largest hedge funds holding Exagen Inc’s share is Platinum Investment Management. It holds Exagen Inc’s shares valued at N/A.


                  Exagen Stock Smart Score

                  The Exagen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Exagen Inc

                  Exagen Diagnostics Inc was incorporated under the laws of the state of New Mexico in 2002. The Company is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.


                  Top 5 ETFs holding XGN

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold XGN. The ETFs are listed according to market value of XGN within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Crispr Therapeutics AG
                  Kura Oncology
                  PTC Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis